BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Prostate cancer AND ATF1, TREB36, 466, ENSG00000123268, P18846 AND Treatment
35 results:

  • 1. Rosiglitazone has a null association with the risk of prostate cancer in type 2 diabetes patients.
    Tseng CH
    Front Endocrinol (Lausanne); 2023; 14():1185053. PubMed ID: 37560306
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Incidence, predictors, and outcomes of febrile neutropenia and neutropenia in patients with metastatic castrate-resistant prostate cancer receiving docetaxel.
    Peltekian S; Sajwani S; Wang X; Kanji S
    Support Care Cancer; 2023 May; 31(5):311. PubMed ID: 37126153
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Out-of-pocket costs for commercially insured patients with localized prostate cancer.
    Wallis CJD; Joyce DD; Klaassen Z; Luckenbaugh AN; Laviana AA; Penson D; Dusetzina SB; Barocas DA
    Urol Oncol; 2021 Dec; 39(12):797-805. PubMed ID: 34600803
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Apalutamide for metastatic, castration-sensitive prostate cancer in the Japanese population: A subgroup analysis of the randomized, double-blind, placebo-controlled phase 3 TITAN study.
    Uemura H; Arai G; Uemura H; Suzuki H; Iijima K; Nishimura K; Fujii K; Hatayama T; Aoyama J; Deprince K; Lopez-Gitlitz A; McCarthy S; Larsen JS; Li J; Chi KN
    Int J Urol; 2021 Mar; 28(3):280-287. PubMed ID: 33295007
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Trends in prostatectomy utilization: Increasing upfront prostatectomy and postprostatectomy radiotherapy for high-risk prostate cancer.
    Kaps B; Leapman M; An Y
    Cancer Med; 2020 Dec; 9(23):8754-8764. PubMed ID: 33128858
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Management Strategies and Patient Selection After a Hospital Funding Reform for prostate cancer Surgery in Canada.
    Wettstein MS; Palmer KS; Kulkarni GS; Paterson JM; Ling V; Lapointe-Shaw L; Li AH; Brown A; Taljaard M; Ivers N
    JAMA Netw Open; 2019 Aug; 2(8):e1910505. PubMed ID: 31469400
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Long-term efficacy and cost-effectiveness of blended cognitive behavior therapy for high fear of recurrence in breast, prostate and colorectal cancer survivors: follow-up of the SWORD randomized controlled trial.
    Burm R; Thewes B; Rodwell L; Kievit W; Speckens A; van de Wal M; Prins J
    BMC Cancer; 2019 May; 19(1):462. PubMed ID: 31096934
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. The prognostic impact of incidental prostate cancer following radical cystoprostatectomy: a nationwide analysis.
    Jønck S; Helgstrand JT; Røder MA; Klemann N; Grønkaer Toft B; Brasso K
    Scand J Urol; 2018; 52(5-6):358-363. PubMed ID: 30624125
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. [Effect of bladder training on bladder function recovery in the male patients after mid-low rectal cancer surgery: a prospective, open, randomized controlled study].
    Xie Y; Wang X; Chen Z; Chi P; Guan G; Lin H; Lu X; Huang Y; Wang Z; Wang M; Chen J; Li X; Wang M; Zheng X; Zheng X; Li R; Lin Q
    Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Nov; 21(11):1255-1260. PubMed ID: 30506536
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Correlation of 3T multiparametric prostate MRI using prostate imaging reporting and data system (PIRADS) version 2 with biopsy as reference standard.
    Mathur S; O'Malley ME; Ghai S; Jhaveri K; Sreeharsha B; Margolis M; Zhong L; Maan H; Toi A
    Abdom Radiol (NY); 2019 Jan; 44(1):252-258. PubMed ID: 30032385
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Brachytherapy monotherapy may be sufficient for a subset of patients with unfavorable intermediate risk prostate cancer.
    King MT; Chen MH; Moran BJ; Braccioforte MH; Buzurovic I; Muralidhar V; Yang DD; Mouw KW; Devlin PM; D'Amico AV; Nguyen PL; Orio PF
    Urol Oncol; 2018 Apr; 36(4):157.e15-157.e20. PubMed ID: 29276060
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Identification of simvastatin-regulated targets associated with JNK activation in DU145 human prostate cancer cell death signaling.
    Jung EJ; Chung KH; Kim CW
    BMB Rep; 2017 Sep; 50(9):466-471. PubMed ID: 28803608
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Measuring the Value of New Drugs: Validity and Reliability of 4 Value Assessment Frameworks in the Oncology Setting.
    Bentley TGK; Cohen JT; Elkin EB; Huynh J; Mukherjea A; Neville TH; Mei M; Copher R; Knoth R; Popescu I; Lee J; Zambrano JM; Broder MS
    J Manag Care Spec Pharm; 2017 Jun; 23(6-a Suppl):S34-S48. PubMed ID: 28535104
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Contemporary Mapping of Post-prostatectomy prostate cancer Relapse with
    Sobol I; Zaid HB; Haloi R; Mynderse LA; Froemming AT; Lowe VJ; Davis BJ; Kwon ED; Karnes RJ
    J Urol; 2017 Jan; 197(1):129-134. PubMed ID: 27449262
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Use of stereotactic body radiotherapy for prostate cancer in the United States from 2004 through 2012.
    Baker BR; Basak R; Mohiuddin JJ; Chen RC
    Cancer; 2016 Jul; 122(14):2234-41. PubMed ID: 27171855
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. When to biopsy seminal vesicles.
    Panach-Navarrete J; García-Morata F; Hernández-Medina JA; Martínez-Jabaloyas JM
    Actas Urol Esp; 2015 May; 39(4):203-9. PubMed ID: 25466644
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Tribulus terrestris versus placebo in the treatment of erectile dysfunction: A prospective, randomized, double blind study.
    Santos CA; Reis LO; Destro-Saade R; Luiza-Reis A; Fregonesi A
    Actas Urol Esp; 2014 May; 38(4):244-8. PubMed ID: 24630840
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Degarelix versus goserelin plus bicalutamide therapy for lower urinary tract symptom relief, prostate volume reduction and quality of life improvement in men with prostate cancer: a systematic review and meta-analysis.
    Cui Y; Zong H; Yan H; Li N; Zhang Y
    Urol Int; 2014; 93(2):152-9. PubMed ID: 24603064
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Gold seed fiducials in analysis of linear and rotational displacement of the prostate bed.
    Ålander E; Visapää H; Kouri M; Keyriläinen J; Saarilahti K; Tenhunen M
    Radiother Oncol; 2014 Feb; 110(2):256-60. PubMed ID: 24332022
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Breast and prostate cancer survivors in a diabetic cohort: results from the Living with Diabetes Study.
    Onitilo AA; Donald M; Stankowski RV; Engel JM; Williams G; Doi SA
    Clin Med Res; 2013 Dec; 11(4):210-8. PubMed ID: 23669614
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.